SciClone Pharmaceuticals (Holdings) Limited

SEHK:6600 Stock Report

Mkt Cap: HK$6.8b

SciClone Pharmaceuticals (Holdings) Past Performance

How has SciClone Pharmaceuticals (Holdings) performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


22.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 6600 has high quality earnings.

Growing Profit Margin: 6600's current net profit margins (31.3%) are lower than last year (37.3%).


Past Earnings Growth Analysis

Earnings Trend: 6600's earnings have grown significantly by 22.2% per year over the past 5 years.

Accelerating Growth: 6600's earnings growth over the past year (6.9%) is below its 5-year average (22.2% per year).

Earnings vs Industry: 6600 earnings growth over the past year (6.9%) exceeded the Pharmaceuticals industry 5.2%.


Return on Equity

High ROE: 6600's Return on Equity (32.2%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies